This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Curtin-Wirt, C. Articles by Pichichero, M. E. Search for Related Content PubMed PubMed Citation Articles by Curtin-Wirt, C. Articles by Pichichero, M. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMOXICILLIN PENICILLIN V PENICILLIN VK Medline Plus Health Information Sore Throat Streptococcal Infections Tonsils and Adenoids Social Bookmarking                         What's this?

Efficacy of Penicillin vs. Amoxicillin in Children with Group A Beta Hemolytic Streptococcal Tonsillopharyngitis

Janet R. Casey, MD

Patrick C. Murray

Carolyn T. Cleary, MD

William J. Hoeger, MD

Steven M. Marsocci, MD

Marie Lynd Murphy, MD

Anne B. Francis, MD

Elmwood Pediatric Group, Rochester, NY

Michael E. Pichichero, MD

Elmwood Pediatric Group, University of Rochester Medical Center, 601 Elmwood Avenue, Box 672, Rochester, NY 14642

The purpose of this study was to compare the bacteriologic and clinical efficacy of oral penicillin versus amoxicillin as first-line therapy for group A beta-hemolytic streptococcal (GABHS) tonsillopharyngitis. The prospective observational study was conducted over 18 months (January 2000-June 2001). Children enrolled had acute onset of symptoms and signs and a laboratory-documented GABHS tonsillopharyngitis illness. Follow-up examination and laboratory testing occurred 10 ± 4 days following completion of treatment. In total, 389 patients were enrolled (intent-to-treat group): 195 received penicillin V and 194 received amoxicillin. Fifty-six of the penicillin-treated and 57 amoxicillin-treated patients refused to take the drug, or were noncompliant, or did not return for the follow-up visit, leaving 276 patients in the per-protocol group: 139 penicillin-treated and 137 amoxicillin-treated. Bacteriologic cure for amoxicillin-treated children occurred in 76% versus 64% in the penicillin-treated children (p=0.04). The clinical cure rate for amoxicillin-treated children was 84% compared to 73% in the penicillin-treated children (p=0.03). Since treatment allocation was not randomized, logistic regression analysis was used to adjust for treatment group differences. The odds ratio (OR) estimate for cure for patients in the amoxicillin versus penicillin V treatment group remained significant (OR=1.84, 95% confidence interval 1.02-3.29); the same was true for clinical cure (OR=1.99, 95% CI=1.02-3.87). Amoxicillin may be superior to penicillin for bacteriologic and clinical cure of GABHS tonsillopharyngitis.

Clinical Pediatrics, Vol. 42, No. 3, 219-225 (2003)
DOI: 10.1177/000992280304200305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. E. Pichichero, J. R. Casey, S. L. Block, R. Guttendorf, H. Flanner, D. Markowitz, and S. Clausen Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2512 - 2520. [Abstract] [Full Text] [PDF]

				J. R. Casey, R. Kahn, D. Gmoser, E. Atlas, K. Urbani, S. Luber, H. Pellman, and M. E. Pichichero Frequency of Symptomatic Relapses of Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis in Children From 4 Pediatric Practices Following Penicillin, Amoxicillin, and Cephalosporin Antibiotic Treatment Clinical Pediatrics, July 1, 2008; 47(6): 549 - 554. [Abstract] [PDF]

				D R Lennon, E Farrell, D R Martin, and J M Stewart Once-daily amoxicillin versus twice-daily penicillin V in group A {beta}-haemolytic streptococcal pharyngitis Arch. Dis. Child., June 1, 2008; 93(6): 474 - 478. [Abstract] [Full Text] [PDF]

				M. E. Pichichero The Importance of Bacteriologic Eradication in the Treatment of Group A Streptococcal Tonsillopharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 3S - 16S. [Abstract] [PDF]

				S. M. Marcy Treatment Options for Streptococcal Pharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 36S - 45S. [Abstract] [PDF]

				M. E. Pichichero Pathogen Shifts and Changing Cure Rates for Otitis Media and Tonsillopharyngitis Clinical Pediatrics, July 1, 2006; 45(6): 493 - 502. [Abstract] [PDF]